Erectile dysfunction: causes, risk factors and management
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York
Nova Science
©2012
|
| Schriftenreihe: | Human sexuality (Nova Science Publishers)
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 |
| Beschreibung: | Includes bibliographical references and index ""ERECTILE DYSFUNCTION ""; ""ERECTILE DYSFUNCTION ""; ""Contents ""; ""Foreword""; ""Part One ""; ""Introduction""; ""References ""; ""A Primary Care Approach to Erectile Dysfunction ""; ""Abstract ""; ""Introduction ""; ""Assessment of ED ""; ""Common Causes of Erectile Dysfunction ""; ""Baseline Investigations ""; ""Men in the Following Categories Require Referral ""; ""Developing a Treatment Plan ""; ""Phase 1: Stabilise General Clinical Condition ""; ""Phase 2: Treat Correctable Causes ""; ""Phase 3: Initiate Specific Therapy for Erectile Dysfunction ""; ""Phase 4: Onward Referral "" ""Conclusion """"References ""; ""Erectile Dysfunction: Causes, Risk Factors and Management ""; ""Abstract ""; ""Introduction ""; ""Epidemiology ""; ""Physiology of Erection ""; ""Pathophysiology of Erectile Dysfunction ""; ""Psychogenic ED ""; ""Neurogenic ED ""; ""Hormonal Causes of ED ""; ""Vascular Causes of ED ""; ""Drug-Induced Erectile Dysfunction ""; ""Erectile Dysfunction due to other Systemic Diseases and Ageing ""; ""Renal Disease ""; ""Spinal Cord Injury ""; ""Correlations of ED with CAD and DM ""; ""Correlation of ED with Lower Urinary Tract Symptoms (LUTS) "" ""Clinical Evaluation """"Quantification of the Severity of Erectile Dysfunction and Improvement ""; ""Physical Examination ""; ""Laboratory Studies ""; ""Special Studies ""; ""Penile Duplex Doppler Imaging ""; ""Management of Erectile Dysfunction ""; ""I. Medical and other Non-surgical Treatment ""; ""Phosphodiesterase Type 5 Inhibitors (PDE5 Inhibitors) ""; ""1. Sildenafil Citrate (Viagra) ""; ""2. Vardenafil (Levitra) ""; ""3. Tadalafil (Cialis) ""; ""4. Use of PDE5 Inhibitors and Cardiovascular Safety ""; ""Apomorphine (Uprima) ""; ""Adrenergic-Receptor Antagonists "" ""1. Phentolamine (Regitine) """"2. Yohimbine ""; ""Trazodone (Desyrel, Mesyrel) ""; ""Dietary Supplements and Erectile Dysfunction ""; ""1. Ginkgo Bilboa ""; ""2. L-Arginine ""; ""Intracavernosal and Intraurethral Therapy ""; ""1. Alprostadil (Prostaglandin E1, Caverject, Medicated Urethral System for Erection) ""; ""2. Papaverine ""; ""3. Phentolamine (Regitine) ""; ""4. Moxisylyte Chlorohydrate ""; ""5. Chlorpromazine (Thorazine) ""; ""6. Vasoactive Intestinal Polypeptide (VIP) ""; ""Testosterone ""; ""Vacuum Constrictive Device ""; ""II. Surgical Treatment "" ""Penile Prostheses Implantation """"Penile Revascularization ""; ""Venectomy ""; ""III. Future Treatments ""; ""Gene Therapy ""; ""1. Gene Therapy and NOS ""; ""2. Gene Therapy and the Human Calcium-Sensitive Potassium Channel Subtype ""; ""3. Gene Therapy and Vascular Endothelial Growth Factor (VEGF) and other Molecular Targets""; ""Conclusion""; ""References ""; ""Current and Emerging Novel Diagnostic Tools for the Diagnosis of Male Erectile Dysfunction ""; ""Abstract ""; ""Introduction ""; ""Consensus and Major International Guidelines on the Investigations of ED "" |
| Beschreibung: | x, 296 pages |
| ISBN: | 1619423200 9781619423206 9781619423169 1619423162 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043774742 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 160920s2012 |||| o||u| ||||||eng d | ||
| 020 | |a 1619423200 |9 1-61942-320-0 | ||
| 020 | |a 9781619423206 |9 978-1-61942-320-6 | ||
| 020 | |a 9781619423169 |9 978-1-61942-316-9 | ||
| 020 | |a 1619423162 |9 1-61942-316-2 | ||
| 035 | |a (ZDB-4-EBA)ocn828140652 | ||
| 035 | |a (OCoLC)972010894 | ||
| 035 | |a (DE-599)BVBBV043774742 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 616.6922 |2 23 | |
| 245 | 1 | 0 | |a Erectile dysfunction |b causes, risk factors and management |c [edited by] Paul Steven Grant |
| 264 | 1 | |a New York |b Nova Science |c ©2012 | |
| 300 | |a x, 296 pages | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Human sexuality (Nova Science Publishers) | |
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a ""ERECTILE DYSFUNCTION ""; ""ERECTILE DYSFUNCTION ""; ""Contents ""; ""Foreword""; ""Part One ""; ""Introduction""; ""References ""; ""A Primary Care Approach to Erectile Dysfunction ""; ""Abstract ""; ""Introduction ""; ""Assessment of ED ""; ""Common Causes of Erectile Dysfunction ""; ""Baseline Investigations ""; ""Men in the Following Categories Require Referral ""; ""Developing a Treatment Plan ""; ""Phase 1: Stabilise General Clinical Condition ""; ""Phase 2: Treat Correctable Causes ""; ""Phase 3: Initiate Specific Therapy for Erectile Dysfunction ""; ""Phase 4: Onward Referral "" | ||
| 500 | |a ""Conclusion """"References ""; ""Erectile Dysfunction: Causes, Risk Factors and Management ""; ""Abstract ""; ""Introduction ""; ""Epidemiology ""; ""Physiology of Erection ""; ""Pathophysiology of Erectile Dysfunction ""; ""Psychogenic ED ""; ""Neurogenic ED ""; ""Hormonal Causes of ED ""; ""Vascular Causes of ED ""; ""Drug-Induced Erectile Dysfunction ""; ""Erectile Dysfunction due to other Systemic Diseases and Ageing ""; ""Renal Disease ""; ""Spinal Cord Injury ""; ""Correlations of ED with CAD and DM ""; ""Correlation of ED with Lower Urinary Tract Symptoms (LUTS) "" | ||
| 500 | |a ""Clinical Evaluation """"Quantification of the Severity of Erectile Dysfunction and Improvement ""; ""Physical Examination ""; ""Laboratory Studies ""; ""Special Studies ""; ""Penile Duplex Doppler Imaging ""; ""Management of Erectile Dysfunction ""; ""I. Medical and other Non-surgical Treatment ""; ""Phosphodiesterase Type 5 Inhibitors (PDE5 Inhibitors) ""; ""1. Sildenafil Citrate (Viagra) ""; ""2. Vardenafil (Levitra) ""; ""3. Tadalafil (Cialis) ""; ""4. Use of PDE5 Inhibitors and Cardiovascular Safety ""; ""Apomorphine (Uprima) ""; ""Adrenergic-Receptor Antagonists "" | ||
| 500 | |a ""1. Phentolamine (Regitine) """"2. Yohimbine ""; ""Trazodone (Desyrel, Mesyrel) ""; ""Dietary Supplements and Erectile Dysfunction ""; ""1. Ginkgo Bilboa ""; ""2. L-Arginine ""; ""Intracavernosal and Intraurethral Therapy ""; ""1. Alprostadil (Prostaglandin E1, Caverject, Medicated Urethral System for Erection) ""; ""2. Papaverine ""; ""3. Phentolamine (Regitine) ""; ""4. Moxisylyte Chlorohydrate ""; ""5. Chlorpromazine (Thorazine) ""; ""6. Vasoactive Intestinal Polypeptide (VIP) ""; ""Testosterone ""; ""Vacuum Constrictive Device ""; ""II. Surgical Treatment "" | ||
| 500 | |a ""Penile Prostheses Implantation """"Penile Revascularization ""; ""Venectomy ""; ""III. Future Treatments ""; ""Gene Therapy ""; ""1. Gene Therapy and NOS ""; ""2. Gene Therapy and the Human Calcium-Sensitive Potassium Channel Subtype ""; ""3. Gene Therapy and Vascular Endothelial Growth Factor (VEGF) and other Molecular Targets""; ""Conclusion""; ""References ""; ""Current and Emerging Novel Diagnostic Tools for the Diagnosis of Male Erectile Dysfunction ""; ""Abstract ""; ""Introduction ""; ""Consensus and Major International Guidelines on the Investigations of ED "" | ||
| 650 | 4 | |a Erectile Dysfunction | |
| 650 | 7 | |a HEALTH & FITNESS / Infertility |2 bisacsh | |
| 650 | 4 | |a Impotence | |
| 650 | 4 | |a Sexual disorders | |
| 650 | 4 | |a Impotence | |
| 650 | 4 | |a Impotence |x Etiology | |
| 650 | 4 | |a Impotence |x Treatment | |
| 700 | 1 | |a Grant, Paul Steven |e Sonstige |4 oth | |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029185801 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=540911 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=540911 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804176599926439936 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043774742 |
| collection | ZDB-4-EBA |
| ctrlnum | (ZDB-4-EBA)ocn828140652 (OCoLC)972010894 (DE-599)BVBBV043774742 |
| dewey-full | 616.6922 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.6922 |
| dewey-search | 616.6922 |
| dewey-sort | 3616.6922 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04641nmm a2200517zc 4500</leader><controlfield tag="001">BV043774742</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">160920s2012 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1619423200</subfield><subfield code="9">1-61942-320-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781619423206</subfield><subfield code="9">978-1-61942-320-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781619423169</subfield><subfield code="9">978-1-61942-316-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1619423162</subfield><subfield code="9">1-61942-316-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-4-EBA)ocn828140652</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)972010894</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043774742</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.6922</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Erectile dysfunction</subfield><subfield code="b">causes, risk factors and management</subfield><subfield code="c">[edited by] Paul Steven Grant</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Nova Science</subfield><subfield code="c">©2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">x, 296 pages</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Human sexuality (Nova Science Publishers)</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">""ERECTILE DYSFUNCTION ""; ""ERECTILE DYSFUNCTION ""; ""Contents ""; ""Foreword""; ""Part One ""; ""Introduction""; ""References ""; ""A Primary Care Approach to Erectile Dysfunction ""; ""Abstract ""; ""Introduction ""; ""Assessment of ED ""; ""Common Causes of Erectile Dysfunction ""; ""Baseline Investigations ""; ""Men in the Following Categories Require Referral ""; ""Developing a Treatment Plan ""; ""Phase 1: Stabilise General Clinical Condition ""; ""Phase 2: Treat Correctable Causes ""; ""Phase 3: Initiate Specific Therapy for Erectile Dysfunction ""; ""Phase 4: Onward Referral ""</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">""Conclusion """"References ""; ""Erectile Dysfunction: Causes, Risk Factors and Management ""; ""Abstract ""; ""Introduction ""; ""Epidemiology ""; ""Physiology of Erection ""; ""Pathophysiology of Erectile Dysfunction ""; ""Psychogenic ED ""; ""Neurogenic ED ""; ""Hormonal Causes of ED ""; ""Vascular Causes of ED ""; ""Drug-Induced Erectile Dysfunction ""; ""Erectile Dysfunction due to other Systemic Diseases and Ageing ""; ""Renal Disease ""; ""Spinal Cord Injury ""; ""Correlations of ED with CAD and DM ""; ""Correlation of ED with Lower Urinary Tract Symptoms (LUTS) ""</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">""Clinical Evaluation """"Quantification of the Severity of Erectile Dysfunction and Improvement ""; ""Physical Examination ""; ""Laboratory Studies ""; ""Special Studies ""; ""Penile Duplex Doppler Imaging ""; ""Management of Erectile Dysfunction ""; ""I. Medical and other Non-surgical Treatment ""; ""Phosphodiesterase Type 5 Inhibitors (PDE5 Inhibitors) ""; ""1. Sildenafil Citrate (Viagra) ""; ""2. Vardenafil (Levitra) ""; ""3. Tadalafil (Cialis) ""; ""4. Use of PDE5 Inhibitors and Cardiovascular Safety ""; ""Apomorphine (Uprima) ""; ""Adrenergic-Receptor Antagonists ""</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">""1. Phentolamine (Regitine) """"2. Yohimbine ""; ""Trazodone (Desyrel, Mesyrel) ""; ""Dietary Supplements and Erectile Dysfunction ""; ""1. Ginkgo Bilboa ""; ""2. L-Arginine ""; ""Intracavernosal and Intraurethral Therapy ""; ""1. Alprostadil (Prostaglandin E1, Caverject, Medicated Urethral System for Erection) ""; ""2. Papaverine ""; ""3. Phentolamine (Regitine) ""; ""4. Moxisylyte Chlorohydrate ""; ""5. Chlorpromazine (Thorazine) ""; ""6. Vasoactive Intestinal Polypeptide (VIP) ""; ""Testosterone ""; ""Vacuum Constrictive Device ""; ""II. Surgical Treatment ""</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">""Penile Prostheses Implantation """"Penile Revascularization ""; ""Venectomy ""; ""III. Future Treatments ""; ""Gene Therapy ""; ""1. Gene Therapy and NOS ""; ""2. Gene Therapy and the Human Calcium-Sensitive Potassium Channel Subtype ""; ""3. Gene Therapy and Vascular Endothelial Growth Factor (VEGF) and other Molecular Targets""; ""Conclusion""; ""References ""; ""Current and Emerging Novel Diagnostic Tools for the Diagnosis of Male Erectile Dysfunction ""; ""Abstract ""; ""Introduction ""; ""Consensus and Major International Guidelines on the Investigations of ED ""</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Erectile Dysfunction</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Infertility</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Impotence</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Sexual disorders</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Impotence</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Impotence</subfield><subfield code="x">Etiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Impotence</subfield><subfield code="x">Treatment</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grant, Paul Steven</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029185801</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=540911</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=540911</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV043774742 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:34:45Z |
| institution | BVB |
| isbn | 1619423200 9781619423206 9781619423169 1619423162 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029185801 |
| oclc_num | 828140652 972010894 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | x, 296 pages |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2012 |
| publishDateSearch | 2012 |
| publishDateSort | 2012 |
| publisher | Nova Science |
| record_format | marc |
| series2 | Human sexuality (Nova Science Publishers) |
| spelling | Erectile dysfunction causes, risk factors and management [edited by] Paul Steven Grant New York Nova Science ©2012 x, 296 pages txt rdacontent c rdamedia cr rdacarrier Human sexuality (Nova Science Publishers) Includes bibliographical references and index ""ERECTILE DYSFUNCTION ""; ""ERECTILE DYSFUNCTION ""; ""Contents ""; ""Foreword""; ""Part One ""; ""Introduction""; ""References ""; ""A Primary Care Approach to Erectile Dysfunction ""; ""Abstract ""; ""Introduction ""; ""Assessment of ED ""; ""Common Causes of Erectile Dysfunction ""; ""Baseline Investigations ""; ""Men in the Following Categories Require Referral ""; ""Developing a Treatment Plan ""; ""Phase 1: Stabilise General Clinical Condition ""; ""Phase 2: Treat Correctable Causes ""; ""Phase 3: Initiate Specific Therapy for Erectile Dysfunction ""; ""Phase 4: Onward Referral "" ""Conclusion """"References ""; ""Erectile Dysfunction: Causes, Risk Factors and Management ""; ""Abstract ""; ""Introduction ""; ""Epidemiology ""; ""Physiology of Erection ""; ""Pathophysiology of Erectile Dysfunction ""; ""Psychogenic ED ""; ""Neurogenic ED ""; ""Hormonal Causes of ED ""; ""Vascular Causes of ED ""; ""Drug-Induced Erectile Dysfunction ""; ""Erectile Dysfunction due to other Systemic Diseases and Ageing ""; ""Renal Disease ""; ""Spinal Cord Injury ""; ""Correlations of ED with CAD and DM ""; ""Correlation of ED with Lower Urinary Tract Symptoms (LUTS) "" ""Clinical Evaluation """"Quantification of the Severity of Erectile Dysfunction and Improvement ""; ""Physical Examination ""; ""Laboratory Studies ""; ""Special Studies ""; ""Penile Duplex Doppler Imaging ""; ""Management of Erectile Dysfunction ""; ""I. Medical and other Non-surgical Treatment ""; ""Phosphodiesterase Type 5 Inhibitors (PDE5 Inhibitors) ""; ""1. Sildenafil Citrate (Viagra) ""; ""2. Vardenafil (Levitra) ""; ""3. Tadalafil (Cialis) ""; ""4. Use of PDE5 Inhibitors and Cardiovascular Safety ""; ""Apomorphine (Uprima) ""; ""Adrenergic-Receptor Antagonists "" ""1. Phentolamine (Regitine) """"2. Yohimbine ""; ""Trazodone (Desyrel, Mesyrel) ""; ""Dietary Supplements and Erectile Dysfunction ""; ""1. Ginkgo Bilboa ""; ""2. L-Arginine ""; ""Intracavernosal and Intraurethral Therapy ""; ""1. Alprostadil (Prostaglandin E1, Caverject, Medicated Urethral System for Erection) ""; ""2. Papaverine ""; ""3. Phentolamine (Regitine) ""; ""4. Moxisylyte Chlorohydrate ""; ""5. Chlorpromazine (Thorazine) ""; ""6. Vasoactive Intestinal Polypeptide (VIP) ""; ""Testosterone ""; ""Vacuum Constrictive Device ""; ""II. Surgical Treatment "" ""Penile Prostheses Implantation """"Penile Revascularization ""; ""Venectomy ""; ""III. Future Treatments ""; ""Gene Therapy ""; ""1. Gene Therapy and NOS ""; ""2. Gene Therapy and the Human Calcium-Sensitive Potassium Channel Subtype ""; ""3. Gene Therapy and Vascular Endothelial Growth Factor (VEGF) and other Molecular Targets""; ""Conclusion""; ""References ""; ""Current and Emerging Novel Diagnostic Tools for the Diagnosis of Male Erectile Dysfunction ""; ""Abstract ""; ""Introduction ""; ""Consensus and Major International Guidelines on the Investigations of ED "" Erectile Dysfunction HEALTH & FITNESS / Infertility bisacsh Impotence Sexual disorders Impotence Etiology Impotence Treatment Grant, Paul Steven Sonstige oth |
| spellingShingle | Erectile dysfunction causes, risk factors and management Erectile Dysfunction HEALTH & FITNESS / Infertility bisacsh Impotence Sexual disorders Impotence Etiology Impotence Treatment |
| title | Erectile dysfunction causes, risk factors and management |
| title_auth | Erectile dysfunction causes, risk factors and management |
| title_exact_search | Erectile dysfunction causes, risk factors and management |
| title_full | Erectile dysfunction causes, risk factors and management [edited by] Paul Steven Grant |
| title_fullStr | Erectile dysfunction causes, risk factors and management [edited by] Paul Steven Grant |
| title_full_unstemmed | Erectile dysfunction causes, risk factors and management [edited by] Paul Steven Grant |
| title_short | Erectile dysfunction |
| title_sort | erectile dysfunction causes risk factors and management |
| title_sub | causes, risk factors and management |
| topic | Erectile Dysfunction HEALTH & FITNESS / Infertility bisacsh Impotence Sexual disorders Impotence Etiology Impotence Treatment |
| topic_facet | Erectile Dysfunction HEALTH & FITNESS / Infertility Impotence Sexual disorders Impotence Etiology Impotence Treatment |
| work_keys_str_mv | AT grantpaulsteven erectiledysfunctioncausesriskfactorsandmanagement |